<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00715546</url>
  </required_header>
  <id_info>
    <org_study_id>ISCMPA 1642/07</org_study_id>
    <nct_id>NCT00715546</nct_id>
  </id_info>
  <brief_title>Autologous Adipose-Derived Stem Cell Transplantation in Patients With Lipodystrophy</brief_title>
  <acronym>AADSCTPL</acronym>
  <official_title>Phase 1 Study of Autologous-Derived Stem Cell Transplantation in Patients With Lipodystrophy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Irmandade Santa Casa de Misericórdia de Porto Alegre</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Irmandade Santa Casa de Misericórdia de Porto Alegre</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to determine the safety of the autologous transplantation of
      adipose-derived stem cells in the treatment of lipodystrophies.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Active, not recruiting</last_known_status>
  <start_date>October 2007</start_date>
  <completion_date type="Anticipated">November 2011</completion_date>
  <primary_completion_date type="Anticipated">August 2011</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Clinical evaluation of the transplanted area.</measure>
    <time_frame>one year</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Presence of neovascularization, adipose transplantation reabsorption, tissue viability</measure>
    <time_frame>one year</time_frame>
  </secondary_outcome>
  <enrollment type="Actual">5</enrollment>
  <condition>Lipodystrophy</condition>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>autologous transplantation of liposuction material enriched with adipose-derived stem cells</intervention_name>
    <description>Lipoinjection enriched with adipose-derived stem-cells.</description>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  lipodystrophies with necessity of fat grafting

          -  accept to participate of the study

        Exclusion Criteria:

          -  HIV infection

          -  Metastatic malignancy

          -  Body mass index &lt; 20 kg/m²

          -  Other severe systemic disease
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Eduardo M. Chem, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Irmandade Santa Casa de Misericórdia de Porto Alegre</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Irmandade Santa Casa de Misericórdia</name>
      <address>
        <city>Porto Alegre</city>
        <state>Rio Grande do Sul</state>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <verification_date>March 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 11, 2008</study_first_submitted>
  <study_first_submitted_qc>July 12, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 15, 2008</study_first_posted>
  <last_update_submitted>June 21, 2011</last_update_submitted>
  <last_update_submitted_qc>June 21, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 22, 2011</last_update_posted>
  <responsible_party>
    <name_title>Eduardo Mainieri Chem, Phd</name_title>
    <organization>Irmandade Santa Casa de Misericórdia de Porto Alegre</organization>
  </responsible_party>
  <keyword>Adipose-derived stem cell</keyword>
  <keyword>Lipodystrophy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lipodystrophy</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

